Rising melanoma incidence rates of the trunk among younger women in the United States.
BACKGROUND
Melanoma rates are rising among young women, possibly due to increasing UV radiation to previously protected body sites. Therefore, we examined melanoma incidence trends by age, gender, and body site. Descriptive methods were complemented with the age-period-cohort parameters net drift and longitudinal age trend.


METHODS
Case and population data were obtained from the Surveillance, Epidemiology, and End Results (SEER) 9 Registries Database (1975-2006). Net drift summarized the average annual percentage change in log-linear rates per year of calendar-time (or year of diagnosis). Longitudinal age trend summarized the average annual percentage change by attained age at diagnosis. Early- and late-onset melanomas have low and high longitudinal age trends, respectively.


RESULTS
There were 105,829 melanomas diagnosed in the SEER 9 Registries. The overall age-adjusted incidence rate (IR) for melanoma was 17.7/100,000 person-years. Age-specific IRs were greater among women than men prior to age 40 years. Among women, IRs decreased for all anatomic sites relative to the trunk. The highest net drift occurred in truncal lesions among women (net drift, 3.8%/year of calendar time; 95% confidence interval, 3.5-4.0%). The lowest longitudinal age trends also were observed for truncal lesions among women (longitudinal age trend, 5.4%/year of attained age; 95% confidence interval, 5.1-5.7).


CONCLUSIONS
Although melanoma IRs overall have risen for decades, the combination of high net drift and low longitudinal age trend show that melanomas are rising preferentially on the trunk among young women.


CONCLUSIONS
Future surveillance and analytic studies should consider melanoma effect modification by age, gender, and body site.
Bradford
Porcia T
PT
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20852, USA. bradfordp@mail.nih.gov
Anderson
William F
WF
Purdue
Mark P
MP
Goldstein
Alisa M
AM
Tucker
Margaret A
MA
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D015331:Cohort Studies; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008545:Melanoma / Q000453:epidemiology* / Q000473:pathology; D008875:Middle Aged; D012042:Registries; D018426:SEER Program; D014481:United States / Q000453:epidemiology; D055815:Young Adult
Int J Epidemiol. 2000 Jun;29(3):416-23
10869312
Biochem Biophys Res Commun. 1994 Mar 30;199(3):1407-12
8147884
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):467-8
18319329
J Am Acad Dermatol. 2008 Dec;59(6):1081-5
19022107
Stat Med. 1987 Jun;6(4):449-67
3629047
Biometrics. 1983 Jun;39(2):311-24
6626659
J Clin Epidemiol. 1999 Jun;52(6):569-83
10408997
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):792-800
19258470
Br J Dermatol. 2008 Apr;158(4):766-72
18241261
Int J Cancer. 1998 Oct 29;78(3):276-80
9766557
Int J Cancer. 2007 Mar 1;120(5):1116-22
17131335
J Am Acad Dermatol. 2007 May;56(5):768-73
17337091
J Clin Oncol. 2006 Jul 1;24(19):3172-7
16809740
Cancer Causes Control. 1992 Nov;3(6):513-6
1420853
Am J Epidemiol. 1990 Dec;132(6):1066-77
2260538
Clin Dermatol. 2009 Jan-Feb;27(1):3-9
19095149
Cancer. 2009 Sep 15;115(18):4176-85
19536874
Eur J Cancer. 2005 Jan;41(1):20-7
15617988
J Natl Cancer Inst. 2002 Oct 16;94(20):1537-45
12381706
J Invest Dermatol. 2008 Dec;128(12):2905-8
18615112
Melanoma Res. 1993 Dec;3(6):395-401
8161879